ArticleJournal of experimental & clinical cancer research : CR2013

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.

Antonio Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.